BlackRock Health Sciences Term Trust launches tender offer for up to 5% of shares at 98% of NAV
BMEZ•BlackRock Health Sciences Term Trust will offer to repurchase up to 5% of its outstanding shares at 98% of NAV. The offer is expected to run from Oct. 16 through Nov. 18, 2026, following a nine-month average discount to NAV of 11.05%.
1. Tender offer details
The closed-end fund plans to repurchase up to 5% of its outstanding common shares at 98% of NAV per share, calculated on the next NAV date after the offer expires. The tender offer is expected to start Oct. 16, 2026, and expire Nov. 18 at 5 p.m. ET; oversubscribed tenders will be prorated, with settlement expected within about five business days after expiration.
2. Discount management trigger
The offer follows a nine-month average discount to NAV of 11.05% through Sept. 30, 2026, triggering the fund’s discount management program.
